Skip to main content
Log in

Implantierbarer Kardioverter/Defibrillator

Implantable Cardioverter Defibrillator

  • Studien-Highlights 2012
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

In diesem Artikel soll eine Übersicht über wichtige, publizierte Arbeiten auf dem Gebiete der Therapie mit dem implantierbaren Kardioverter/Defibrillator (ICD) im Jahre 2012 gegeben werden. Wesentliche Arbeiten betrafen Analysen zur Therapieeffektivität und -sicherheit des subkutan implantierbaren ICD, zu geschlechtsspezifischen Unterschieden in der Komplikationsrate und Prognose nach ICD-Implantation, zur Notwendigkeit der intraoperativen Testung der Defibrillationsschwelle und zur Beeinflussung der Prognose nach ICD-Implantation durch Verhinderung von ICD-Schockentladungen. Die Relevanz der Studienergebnisse für den klinischen Alltag wird jeweils kurz diskutiert.

Abstract

This article aims to give an overview over important articles in the field of implantable cardioverter defibrillator (ICD) therapy in 2012. Important publications concern analyses on therapy efficacy and safety of the subcutaneous ICD, gender-specific differences in the complication rate and prognosis after ICD implantation, the necessity of intraoperative testing of the defibrillation threshold and the impact of preventive measures to reduce ICD therapies on prognosis after device implantation. The relevance of the study findings for daily clinical practice is briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol 5(5):913–919

    Article  PubMed  Google Scholar 

  2. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363(1):36–44

    Article  PubMed  CAS  Google Scholar 

  3. Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D’Acri MG, Klersy C, Gasparini M, SAFE-ICD Study Investigators (2012) Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol 60(11):981–987

    Article  PubMed  Google Scholar 

  4. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, for the CONNECT Investigators The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial. (2011) The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181–1189

    Article  PubMed  Google Scholar 

  5. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C (2009) Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 169(16):1500–1506

    Article  PubMed  Google Scholar 

  6. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC (2012) Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 23(4):359–366

    Article  PubMed  Google Scholar 

  7. Ha AH, Ham I, Nair GM, Connolly SJ, Dorian P, Morillo CA, Healey JS (2012) Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm 9:2068–2074

    Article  PubMed  Google Scholar 

  8. Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS (2012) A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial. J Cardiovasc Electrophysiol 23(12):1313–1316

    Article  PubMed  Google Scholar 

  9. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators. The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125:2985–2992

    Article  PubMed  Google Scholar 

  10. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283

    Article  PubMed  CAS  Google Scholar 

  11. Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60(19):1933–1939

    Article  PubMed  Google Scholar 

  12. Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA (2012) Rationale and design of the PRAETORIAN trial: a prospective, randomized comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy. Am Heart J 163(5):753–760

    Article  PubMed  Google Scholar 

  13. Pedersen SS, Lambiase P, Boersma LV, Murgatroyd F, Johansen JB, Reeve H, Stuart AG, Adragao P, Theuns DA (2012) Evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry. Pacing Clin Electrophysiol 35(5):574–579

    Article  PubMed  Google Scholar 

  14. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359(10):1009–1017

    Article  PubMed  CAS  Google Scholar 

  15. Russo AM, Daugherty SL, Masoudi FA, Wang Y, Mazzarelli J, Curtis J, Lampert R (2012) Gender and outcomes following primary prevention ICD placement: analysis of the NCDR ICD registry. Circulation 126:A9310

    Google Scholar 

  16. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A (2010) Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 7(7):876–882

    Article  PubMed  Google Scholar 

  17. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up. The ALTITUDE survival study. Circulation 122:2359–2367

    Article  PubMed  Google Scholar 

  18. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes M, Ferguson TB, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 126:1784–1800

    Article  PubMed  Google Scholar 

  19. Varma N, Michalski J, Epstein AE, Schweikert R (2010) Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance the Lumos-T safely Reduces Routine Office Device Follow-up (TRUST) Trial. Circ Arrhythm Electrophysiol 3:428–436

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Stellbrink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stellbrink, ., Andresen, D., Böcker, D. et al. Implantierbarer Kardioverter/Defibrillator. Herzschr Elektrophys 24, 75–78 (2013). https://doi.org/10.1007/s00399-013-0265-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-013-0265-7

Navigation